Atlas Trials

Nicotinamide Riboside With and Without Resveratrol to Improve Functioning in Peripheral Artery Disease

Clinical trial NCT03743636 · COMPLETED

Trial details

NCT number
NCT03743636
Sponsor
Northwestern University
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Peripheral Artery Disease
Start date
2018-10-01
Primary completion
2023-05-23
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.